Beyond Biotech podcast 1: Forbion, OMass, PharNext
It's the first official Beyond Biotech podcast! And this week, we have three interviews. We…
It's the first official Beyond Biotech podcast! And this week, we have three interviews. We…
European life sciences venture capital firm Forbion, has announced the first €470M ($500M) close of…
More than a year after biotech stock indices peaked, the markets are worse than ever.…
The year 2021 is closing with a biotech investment rush as Eir Ventures, Apollo Health…
The Dutch life sciences venture capital firm Forbion has bagged €185M in the first closing…
A Series B funding round has whipped up €40M for the Irish company Inflazome. This…
Update: The European venture capital firm Forbion closed fundraising for it's fourth life sciences fund…
Enterprise Therapeutics has raised a substantial Series B financing round to bring its treatments for…
NorthSea Therapeutics has been founded in the Netherlands to develop a drug against NASH, a…
A panel of experts in immuno-oncology discussed the challenges and opportunities to develop therapies that can…
Sander van Deventer is now a managing partner at Forbion after playing a critical role…
Pharma would seemingly best biotech in any competition. A few CEOs explain why it left the honor…